Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.

NCT02975596 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02975596
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02975596 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing and Evaluating a School and University Campus-Based Approach to Implementing Serogroup B Meningococcal (MenB) Disease Recommendations in Older Adolescents and Young Adults.
Lead sponsor
University of Florida
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2016
Completion date
October 8, 2019
Enrollment
1,326 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

meningococcal vaccine